CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 66 enrolled
Drug / intervention
Cellvizio needle-based Confocal Laser Endomicroscopy (nCLE) systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01236300
NCT01236300N/ACompleted
CompareCT.gov

In Vivo nCLE Study in the Pancreas With Endosonography of Cystic Tumors

University of Chicago·interventional·Posted Nov 8, 2010·Updated Jun 8, 2016

In Brief

A clinical study evaluating Cellvizio needle-based Confocal Laser Endomicroscopy (nCLE) system for Pancreatic Cysts. Completed, enrolled 66 participants across 1 site.

Detailed Summary

Assess the safety and efficacy of the Cellvizio needle-based Confocal Laser Endomicroscopy (nCLE) system in differentiating benign from malignant and premalignant cysts (e.g. mucinous from non-mucinous cysts)

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPancreatic Cysts
CountriesUnited States
CollaboratorsMauna Kea Technologies, Institut Paoli-Calmettes, Technical University of Munich, Yale University, University of California, Irvine, Mayo Clinic, University of Washington, Cedars-Sinai Medical Center

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedNov 8, 2010
Enrollment StartJul 1, 2010
Primary CompletionAug 1, 2011
Study CompletionMay 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 15.7 years ago

Interventions

Cellvizio needle-based Confocal Laser Endomicroscopy (nCLE) systemdevice